10x Genomics (TXG) Accumulated Expenses (2018 - 2026)

10x Genomics has disclosed Accumulated Expenses across 9 years of filings, most recently posting $30.4 million for Q2 2026.

• In Q2 2026, Accumulated Expenses fell 22.24% year-over-year to $30.4 million; the TTM figure through Jun 2026 stood at $30.4 million (down 22.24% YoY), while the FY2025 annual figure was $42.5 million, up 3.24% from the prior year.
• Accumulated Expenses came in at $30.4 million for Q2 2026 at 10x Genomics, down from $33.7 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $62.0 million in Q3 2022 to a low of $30.4 million in Q2 2026.
• Average Accumulated Expenses over 5 years is $43.6 million, with a median of $42.4 million recorded in 2024.
• Year-over-year, Accumulated Expenses surged 47.2% in 2022 and sank 41.51% in 2023.
• Over 5 years, Accumulated Expenses stood at $59.8 million in 2022, then fell by 5.24% to $56.6 million in 2023, then decreased by 27.33% to $41.2 million in 2024, then advanced by 3.24% to $42.5 million in 2025, then slipped by 28.52% to $30.4 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $30.4 million in Q2 2026, $33.7 million in Q1 2026, and $42.5 million in Q4 2025.